Doctors are celebrating the “unprecedented” trial results of a cancer treatment that's managed to eliminate tumors in some patients who have proven resistant to other treatments.
The injection, called amivantamab and developed by Johnson & Johnson, was tested in an 11-nation clinical trial in which it was administered to patients whose cancer had either spread or returned after other treatments failed.
